#EldersFirst · Care plans, services and products for older adults
Emoha #EldersFirst

Know How Effective the Intranasal Covid-19 Vaccine is Against Other Vaccines

India is finally seeing a decline in the number of COVID-19 cases after being hit by the number in crores during the first and second wave. In the fright of the third wave of this deadly virus, the administration of vaccines have become rapid.

5 min read · Updated 2023-10-10

Hand-drawn line illustration of a pair of lungs, a handheld shower and grab bar and a stethoscope for the guide "India's first indigenous Intranasal Covid Vaccine Bharat"

Overview

In the seam of current ongoing research around the globe for various COVID-19 vaccines, there is one, which comes in the form of a nasal spray. Bharat Biotech’s ‘nasal spray’ vaccine which is India’s indigenous internasal vaccine has presently received the regulatory approvals for its phase-2 trials.

What is an Internasal Vaccine and How does it work?

An internasal vaccine is a type of vaccine which is administered to a person by the nose, instead of the usual injections. It is non-invasive, painless, economically cheaper, and easier to administer. Internasal vaccines are very much like a regular nose spray and the dose goes right into the respiratory tract. A vital and only example of internasal vaccine is the Live Attenuated Infleunza Vaccine [LIAV (FluMist) Vaccine].

Now that we all know the meaning of internasal vaccine, let’s go ahead and understand how it works. Since it is administered through the nose, it goes into the respiratory tract and works by inducing immunity through the inner surface of the nose or the respiratory pathway as the respitory pathway comes in contact with numerous microbes. It supposedly starts to work in about two weeks. The aim of this vaccine is to neutralize the virus in the nostrils itself so that the virus doesn’t get deep down into one’s system.

Hand-drawn line illustration of a weekly pill organiser, a pair of lungs and a pump bottle of skin care, for the section "What is an Internasal Vaccine and How does it work?" of India's first indigenous Intranasal Covid Vaccine Bharat
Illustration: What is an Internasal Vaccine and How does it work?

How is Nasal Vaccine different from other vaccines in regards to COVID-19?

Numerous microbes including the coronavirus enter the body through mucosa (tissue that lines the entire respiratory tract) and cause a response in the cells present in the nose, mouth, lungs, and digestive tract. The usual intermuscular vaccines do a lousy job at producing a reciprocal action for this mucosal response since its mechanism is basically creating immune cells elsewhere and transporting them to the site. The internasal vaccine however, helps make protein in the respiratory tract and increases immunity. So basically, internasal vaccine unlike other COVID-19 vaccines in India, targets the initial site of infection and causes a better and widespread immune response.

If an internasal vaccine dose is effective, it will help in preventing the contraction of COVID-19 as well as it will reduce the spread of the disease since it increases the immunity in the mucosal membrane.

Another advantage of the nasal spray vaccine is that it does not require health workers since it is not administered by a needle.

The 1st Internasal vaccine for COVID-19 in India

India’s first indigenous internasal vaccine has been developed by Bharat Biotech in collaboration with Washington University school for the treatment of COVID-19. Bharat Biotech’s nasal vaccine known as BBV154 is also the first COVID-19 vaccine of its kind to undergo human clinical trials in India. The advancement of the vaccine has been supported by The Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC). It is a replication-deficient chimpanzee adenovirus SAES-CoV-2 vectored vaccine.

The BBV154 intranasal vaccine was discovered to be safe and immunogenic in the pre-clinical toxicity studies and was found to be able to obtain high level of neutralizing antibodies in the animal studies (has found to be effective in preventing infection in mice against COVID-19). It is a live attenuated vaccine which means it contains the weakened or inactive form of the virus itself. Phase-1 clinical trials for the vaccine have been completed in adults being over the age of 18 and that of below 60. They have been under observation since then. About 30 volunteers including doctors, their family members, and several others have taken the dose. According to the recent nasal vaccine update, the doses of the vaccine that were administered in Phase-1 to healthy volunteers have been well endured with no adverse events. Two drops of the internasal vaccine were put into each nostril of each volunteer. Total of eight vaccine drops in pairs of two were administered in the interval of 5 minutes to each person. The volunteers were then observed for over an hour before being allowed to leave. Later, saliva and blood samples were collected for testing and studying immunogenicity.

It is the first internasal vaccine that has received the regulatory approval for Phase-2 trials which are randomized and have commenced at Prakhar hospital in Kanpur which is the only center where trials of nasal vaccine against COVID-19 are being done. The Bharat Biotech internasal vaccine can be a game-changer if it proves to be successful, as it can boost India’s vaccination drive. This vaccine is presumed to be appropriate and convenient to be administered in children.

The manufacturer of Covaxin- Bharat Biotech is expected to produce about ten crore doses of its nasal vaccine against COVID-19 by the end of the year. In its Phase-3 trials, covaxin has shown 70-80% efficacy against symptomatic COVID-19 and about 90-95% against severe COVID-19.

Various other countries such as China, The United States, and Netherlands have been conducting research for the nasal vaccine against the deadly COVID-19. The nasal vaccine update from around the world is that China approved the trial phase for the nasal vaccine in September.

Vaccines for COVID-19 today

This article describes the approval of a nasal COVID-19 vaccine during the third-wave period. COVID-19 vaccines, boosters and national policy have changed since then, so please check with your doctor, the CoWIN portal or the Ministry of Health and Family Welfare for current recommendations.

Hand-drawn line illustration of a heart and pulse line, a pair of lungs and an oxygen cylinder, for the section "Vaccines for COVID-19 today" of India's first indigenous Intranasal Covid Vaccine Bharat
Illustration: Vaccines for COVID-19 today

How to think about vaccines

  • Different vaccines work differently. Injected vaccines produce antibodies in the blood. Nasal vaccines aim to produce immunity in the nose and airways, where the virus enters. Researchers study how effective each type is, how long protection lasts, and in which age groups.
  • Safety monitoring continues. Reputable health authorities track side effects and update guidance. Report any unusual symptoms after vaccination to your doctor or vaccination centre.
  • Older adults benefit most from staying up to date. People over 60 and those with long-term conditions are at higher risk of severe illness, so doctors often advise them to stay up to date with recommended vaccines.
  • Check eligibility and schedule. Ask your doctor which vaccine, how many doses and what interval are right for you.
  • Mixing and brands. Do not choose by yourself. Follow professional advice.
  • Nasal vaccines may not suit people with certain conditions, such as a blocked nose or specific allergies. Follow the instructions from the health professional giving the vaccine.

Other vaccines to ask about

Influenza (yearly), pneumococcal, tetanus and diphtheria booster, shingles, and others based on health conditions or travel. Keep a vaccination record.

Continuing protective habits

  • Wash hands, and ventilate rooms.
  • Wear a mask in crowded or poorly ventilated places, or if you have symptoms.
  • Stay home when unwell.
  • Keep a thermometer and pulse oximeter at home, and know whom to call.
  • Seek medical help early for fever, cough or breathing difficulty.

Beware of misinformation

Rumours and fake news about vaccines spread quickly. Use official sources such as government health websites or your doctor, not forwarded messages.

This guide is general information, not medical advice.

Related Posts :

Tags: Covid -19 #VaccineBreathing supportFingertip pulse oximeterCompressor nebuliserHealth monitoring devicesHealthy ageingElder care

Written by the Emoha editorial team. General information only.

This article is for general education and is not medical advice. Ask a doctor or pharmacist about your own situation before changing any exercise, diet or medicine.

Talk to a care advisor

Tell us about your parent. We will call you back and suggest a plan.

See care plans and prices

Request a call back

Tell us a little and we will call you back. No obligation.

Add more details (optional)